Clinical Trials
7 trialsNCT05651178 2026-06-04
Human CD19-CD22 Targeted T Cells Injection for Refractory/Relapsed Central Nervous System Leukemia/Lymphoma Patients
Hrain Biotechnology Co., Ltd.
Phase EARLY_PHASE1 Active not recruiting
NCT04541108 2026-05-22
Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies
Presage Biosciences
Phase EARLY_PHASE1 Active not recruiting
NCT06959563 2026-05-20
9vHPV-BCG
Medicine Invention Design, Inc
Phase EARLY_PHASE1 Active not recruiting
NCT05023551 2025-09-16
Study of DSP-0390 in Patients With Recurrent High-Grade Glioma
Sumitomo Pharma America, Inc.
Phase EARLY_PHASE1 Active not recruiting
NCT03305341 2025-06-11
COVSP-BCG
Medicine Invention Design, Inc
Phase EARLY_PHASE1 Active not recruiting
NCT05302648 2025-01-03
To Evaluate the Safety and Efficacy of Human Derived Anti-BCMA CAR-T Injection for Subjects with R/R MM
Hrain Biotechnology Co., Ltd.
Phase EARLY_PHASE1 Active not recruiting
NCT06635434 2024-10-26
An English/Spanish Mobile Augmented Reality Pain Assessment App for Hispanic/Latino Pediatric Cancer Patients
ALTality, Inc.
Phase EARLY_PHASE1 Active not recruiting